HSF2 and small cell lung carcinoma: The results directly demonstrated the involvement of HSF2 in colorectal cancer, renal cell carcinoma, hepatocellular carcinoma, endometrial cancer, small cell lung cancer, chronic myeloid leukemia, and viral carcinogenesis (Figures 6, 7).